Brain metastases treated with CyberKnife and TomoTherapy: A report of three cases.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 3, p. 99, doi. 10.4103/glioma.glioma_23_22
- By:
- Publication type:
- Article
Works matching IS 25896113 AND DT 2022 AND VI 5 AND IP 3
Results: 6
1
2
Progress on TTFields combined with other therapies for glioblastoma treatment: A narrative review.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 3, p. 90, doi. 10.4103/glioma.glioma_12_22
- By:
- Publication type:
- Article
3
Associations of O6-methylguanine-DNA methyltransferase promoter methylation status with age and 1p/19q codeletion status in isocitrate dehydrogenase mutation gliomas based on an Asian cohort: A narrative review.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 3, p. 87, doi. 10.4103/glioma.glioma_25_22
- By:
- Publication type:
- Article
4
Research progress of drug resistance mechanisms to temozolomide in glioblastoma: A narrative review.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 3, p. 81, doi. 10.4103/glioma.glioma_24_22
- By:
- Publication type:
- Article
5
Corrigendum: Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 3, p. 110, doi. 10.4103/glioma.glioma_19_22
- Publication type:
- Article
6
WHO grade III diffuse astrocytic glioma in a 35-year-old male.
- Published in:
- Glioma (2589-6113), 2022, v. 5, n. 3, p. 107, doi. 10.4103/glioma.glioma_26_22
- By:
- Publication type:
- Article